Back to Search
ANDREA MILLER, MD
MD
Internal Medicine Physician
NPI: 1710961909Individual
Education
OTHER
Class of 1998
Clinical Trials (4)
4
Linked Trials
0
Recruiting
4
With Results
A Study of Infliximab for Treatment Resistant Major Depression
NCT00463580COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
NCT04352101COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation
NCT02796755COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
NCT00352885COMPLETEDPHASE4STUDY_CHAIR
Research & Publications (20)
Antidepressants for the treatment of depression in people with cancer.
PMID 36999619·Cochrane Database Syst Rev·2023
6-review
Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.
PMID 25529904·Brain Behav Immun·2015
2-rct
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.
PMID 23624296·Brain Behav Immun·2013
2-rct
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
PMID 22945416·JAMA Psychiatry·2013
4-observational
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
PMID 23575741·Neuropsychopharmacology·2013
2-rct
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
PMID 22353759·Neuropsychopharmacology·2012
4-observational
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
PMID 18519725·Antimicrob Agents Chemother·2008
7-preclinical
Reproducing stone monument photosynthetic-based colonization under laboratory conditions.
PMID 18768211·Sci Total Environ·2008
8-other
Gene therapy needs robust synthetic nonviral platform technologies.
PMID 14695512·Chembiochem·2004
8-other
Order for free: molecular diversity and complexity promote self-organisation.
PMID 17590952·Chembiochem·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1669 W INA RD STE 101
TUCSON, AZ 85704 - Phone
- (520) 795-6183
Quick Facts
- NPI
- 1710961909
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile